When Medicine Is Out of Reach: What and where is the place of traditional medicine and the world of biology in the rise of inaccessible healthcare?

In many parts of the world, the question about whether medication is working, is not if people are getting medicated but it is whether or if at all, it is reachable. Between overstretched hospitals, rising costs, and uneven scientific infrastructure, healthcare has become increasingly inaccessible to large segments of the global population. In that gap, biology does not pause. Pathogens continue to evolve, ecosystems continue to shift, and communities, often out of necessity, turn to alternative systems of healing that have existed for centuries.

This tension between modern healthcare limitations and the enduring presence of traditional medicine raises, the questions, on whether we are overlooking biological solutions simply because they fall outside dominant scientific frameworks.

 

When Healthcare Fails, Biology Adapts

Despite, inaccessible healthcare being a social or economic issue, it cannot be linked away from the biological aspect in which some of the microbes that causes disease tend to exhibit on a daily basis. When diseases go untreated or are inconsistently managed, they do not remain static, as somewhat believed, but in contrast they adapt.

Delayed or incomplete treatment allows pathogens (disease causing microbes) more time to replicate, mutate, and potentially develop resistance. This is especially evident in bacterial infections, where inconsistent antibiotic use has accelerated antimicrobial resistance (AMR). In regions where access to consistent medical care is limited, patients may start treatment late, stop midway due to cost, or rely on suboptimal alternatives. Each of these scenarios creates an environment where stronger, more resilient strains of pathogens can emerge.

The consequences extend beyond individual patients. At a population level, untreated or poorly managed infections increase transmission rates, alter disease dynamics, and place additional strain on already fragile healthcare systems. Diseases that might otherwise be contained become endemic, circulating continuously within communities.

Compounding, the aspect of microbes going about evolving and adapting, is the uneven pace of pharmaceutical and scientific advancement across regions. While some parts of the world benefit from cutting-edge therapies and rapid vaccine development, others face shortages of basic medicines, limited laboratory capacity, and underfunded research institutions. This disparity creates a fragmented global health landscape, one where biology evolves under very different pressures depending on geography.

For the biological world, this means more opportunity for pathogens to exploit gaps. Where healthcare systems are slow, under-resourced, or inaccessible, diseases are given space to persist, adapt, and sometimes re-emerge in more complex forms.

 

A Changing World: Pathogens, Vectors, and New Realities

The rise of new and resurgent diseases is not happening in isolation. It is deeply tied to environmental change, human behavior, and shifting ecosystems.

Vector organisms (hosts for pathogens) such as mosquitoes and ticks, often, play a crucial role in disease transmission. As global temperatures rise, these vectors expand into various other environments, bringing diseases with them. Malaria, dengue, and other vector-borne illnesses are now appearing in regions where they were previously uncommon. Biology, once again, is responding to environmental change.

Urbanization adds another layer. Rapid population growth in cities often outpaces infrastructure development, leading to overcrowding, inadequate sanitation, and increased transmission risks. At the same time, rural areas are undergoing their own transformations. Expanding human activity, such as expanding farms, increasing forestry and many more, into previously undisturbed ecosystems increases contact with wildlife, raising the likelihood of zoonotic spillover (transfer of pathogens from humans to animals and vice versa), when diseases jump from animals to humans.

The COVID-19 pandemic illustrated how interconnected these factors are. A single pathogen, emerging under the right ecological and social conditions, was able to spread globally within months. It exposed both the strengths and vulnerabilities of modern healthcare systems, while also highlighting disparities in access to treatment and vaccines.

Together, these dynamics reinforce a central idea, that we highlighted earlier, regarding, biology not being separate from society. It responds to how we live, how we build, and how we care, or fail to care, for one another.

 

Traditional Medicine: Between Skepticism and Scientific Promise

In regions where formal healthcare systems are limited or inaccessible, traditional medicine often happens to be the primary form of care. Yet despite its widespread use, it remains caught between skepticism and curiosity within the scientific community.

At its core, traditional medicine is deeply biological. Many remedies are derived from plants rich in bioactive compounds, such as, phytochemicals that can have antimicrobial, anti-inflammatory, or analgesic properties. Some of the most important medical breakthroughs have roots in traditional knowledge. Treatments for malaria and other diseases have emerged from plants that were used for generations before being studied in laboratories.

Today, similar potential exists across a wide range of traditional practices. Certain plant extracts show promising antibacterial and antiviral activity. Fermented remedies may influence the gut microbiome, an area of increasing interest in modern biology. Even compounds once dismissed as purely cultural or recreational, such as cannabis and other psychoactive substances, are now being explored for their role in managing chronic pain, neurological conditions, and mental health disorders.

In clinical and experimental settings, these substances have shown measurable effects on inflammation, neural pathways, and pain perception. This suggests that traditional knowledge systems may hold insights into biological mechanisms that are only now being understood through modern science. Yet, much of this potential remains underexplored.

 

The Scientific Gap: Knowledge, Funding, and Incentives

If traditional medicine shows promise, why has it not been more fully integrated into mainstream healthcare?

Part of the answer lies in the structure of scientific research itself. Modern pharmaceutical development is resource-intensive, requiring large-scale clinical trials, standardized compounds, and regulatory approval processes. Natural remedies, which can vary in composition depending on how they are grown, harvested, and prepared, are difficult to standardize and commercialize.

Funding also plays a critical role. Research into traditional medicine often receives less financial support compared to synthetic drug development. This is partly due to economic incentives, where pharmaceutical companies are more likely to invest in treatments that can be patented and sold at scale. Many traditional remedies, by contrast, are part of shared cultural knowledge, making them less attractive from a profit perspective.

This introduces a deeper tension between profit and public good. Should the value of a treatment be determined by its market potential, or by its ability to improve health outcomes? And what happens when potentially effective remedies are overlooked because they do not fit within existing economic models?

There are also ethical considerations. The study and commercialization of traditional knowledge raise questions about ownership, consent, and benefit-sharing. Communities that have preserved this knowledge for generations are not always included in the scientific or financial rewards that follow.

 

Risks, Realities, and Misconceptions

While it is important to explore the potential of traditional medicine, it is equally important to approach it with critical thinking. Not all traditional remedies are safe or effective. Some may contain toxic compounds, interact negatively with other medications, or lack sufficient evidence to support their use. Dosage can be inconsistent, and preparation methods may vary widely, making outcomes unpredictable.

One of the most significant risks is the delay in seeking proven medical treatment. When serious conditions are treated solely with unverified remedies, the consequences can be severe. At the same time, dismissing traditional medicine entirely overlooks its historical and practical value. Many modern treatments have origins in traditional practices, and ongoing research continues to uncover biologically active compounds in natural sources. The goal, then, is not to replace one system with another, but to evaluate both with the same level of scientific rigor.

 

Toward an Integrated Future: Biology, Culture, and Care

Perhaps the most compelling path forward lies in integration. An interdisciplinary approach, combining modern biomedical research with traditional knowledge has the potential to expand our understanding of health and disease. This includes not only studying plant-based remedies, but also examining how cultural practices shape health outcomes.

In many communities, traditional medicine is not limited to physical treatment. It is embedded within social and spiritual frameworks, including healing ceremonies, communal care, and holistic approaches to well-being. These practices reflect an understanding of health that goes beyond the biological to include psychological and social dimensions.

Anthropologically, this raises important questions. What can these systems teach us about resilience, community health, and the relationship between humans and their environment? And how might these insights be applied in modern urban settings, where social isolation and lifestyle-related diseases are increasingly common?

Cities, in many ways, have lost some of the biological and cultural connections that underpin traditional health systems. Reintegrating these perspectives, while maintaining scientific standards, could lead to more inclusive and adaptable models of care.

 

Rethinking What Counts as Medicine

As healthcare systems face growing challenges, from rising costs to emerging diseases, the need for new approaches becomes increasingly urgent. Traditional medicine, often overlooked or underestimated, represents a vast and largely untapped resource. By unlocking its potential, it often requires more than curiosity. It demands rigorous research, ethical collaboration, and a willingness to question existing assumptions about what constitutes valid medical knowledge.

Biology does not operate within disciplinary boundaries, but responds to environments, behaviors, and systems, whether they are rooted in modern science or centuries-old traditions. The future of healthcare may not lie in choosing between these systems, but in understanding how they can inform and strengthen one another.